Atypical antipsychotic-induced diabetes mellitus in child and adolescent psychiatry.
Authors:
- Saskia HuininkSHSaskia Huinink
- 1 January 2007
- journal article
- Published by Springer Nature in CNS Drugs
- Vol. 21 (12) , 1035-8
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- An Open-Label Study of Olanzapine in Children and Adolescents with SchizophreniaJournal of Psychiatric Practice, 2007
- Risk of Diabetic Ketoacidosis after Exposure to Risperidone or OlanzapineDrug Safety, 2007
- Safety and Usage of Atypical Antipsychotic Medicines in ChildrenDrug Safety, 2007
- Weight gain associated with clozapine, olanzapine and risperidone in children and adolescentsJournal of Neural Transmission, 2006
- Management of psychiatric disorders in children and adolescents with atypical antipsychoticsEuropean Child & Adolescent Psychiatry, 2006
- Differential trends in prevalence of diabetes and unrelated general medical illness for schizophrenia patients before and after the atypical antipsychotic eraSchizophrenia Research, 2006
- Diabetes and its prevention: Pragmatic solutions for people with schizophreniaThe British Journal of Psychiatry, 2004
- Atypical Antipsychotics and New Onset Diabetes mellitusPharmacopsychiatry, 2004
- Hyperglycemia from Olanzapine Treatment in AdolescentsJournal of Child and Adolescent Psychopharmacology, 2003
- Atypical Antipsychotic Drugs and Hyperglycemia in AdolescentsJAMA, 2001